IL1B and COVID-19: IL-1-mediated inflammation in COVID-19-associated acute lung injury (ALI) follows the biological path of NLRP3 inflammasome and caspase-1 activation, leading to production of major innate immune mediators, IL-1β and IL-18 [81].